カテゴリー： QYResearch, 世界

世界のB細胞成熟抗原（BCMA）標的療法市場

QYResearchが発行した調査報告書（DATA909X04452）
◆英語タイトル：Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Professional Survey Report 2019
◆商品コード：DATA909X04452
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2019年11月15日（※2024年版があります。お問い合わせください）
◆ページ数：110
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
※本調査レポートは、B細胞成熟抗原（BCMA）標的療法の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、二重特異性抗体、抗体薬物コンジュゲート、キメラ抗原受容体T細胞に、用途別には、肝臓がん、呼吸器がん、脳がん、その他にセグメント区分し、B細胞成熟抗原（BCMA）標的療法の世界市場を分析しました。


・エグゼクティブ・サマリー
・B細胞成熟抗原（BCMA）標的療法の世界市場概要
・B細胞成熟抗原（BCMA）標的療法の製造コスト構成分析
・B細胞成熟抗原（BCMA）標的療法の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・B細胞成熟抗原（BCMA）標的療法の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・B細胞成熟抗原（BCMA）標的療法のセグメント分析（種類別）
（二重特異性抗体、抗体薬物コンジュゲート、キメラ抗原受容体T細胞）
・B細胞成熟抗原（BCMA）標的療法のセグメント分析（用途別）
（肝臓がん、呼吸器がん、脳がん、その他）
・B細胞成熟抗原（BCMA）標的療法の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Transposagen Biopharmaceuticals、Sutro Biopharma、Malin Corporation、Eureka Therapeutics、firstVentury Equity、Five Prime Therapeutics、Credit Suisse Securities、Dana-Farber Cancer Institute、Deerfield Partners、Onyx Pharmaceuticals、Juno Therapeutics、）
・B細胞成熟抗原（BCMA）標的療法の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global B-Cell Maturation Antigen(BCMA) Targeted Therapies market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on B-Cell Maturation Antigen(BCMA) Targeted Therapies volume and value at global level, regional level and company level. From a global perspective, this report represents overall B-Cell Maturation Antigen(BCMA) Targeted Therapies market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of B-Cell Maturation Antigen(BCMA) Targeted Therapies in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their B-Cell Maturation Antigen(BCMA) Targeted Therapies manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Transposagen Biopharmaceuticals
Sutro Biopharma
Malin Corporation
Eureka Therapeutics
firstVentury Equity
Five Prime Therapeutics
Credit Suisse Securities
Dana-Farber Cancer Institute
Deerfield Partners
Onyx Pharmaceuticals
Juno Therapeutics

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Bispecific Antibodies
Antibody Drug Conjugates
Chimeric Antigen Receptor T-Cells

Segment by Application
Liver Cancer
Respiratory Cancer
Brain Cancer
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of B-Cell Maturation Antigen(BCMA) Targeted Therapies
1.1 Definition of B-Cell Maturation Antigen(BCMA) Targeted Therapies
1.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Segment by Type
1.2.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Bispecific Antibodies
1.2.3 Antibody Drug Conjugates
1.2.4 Chimeric Antigen Receptor T-Cells
1.3 B-Cell Maturation Antigen(BCMA) Targeted Therapies Segment by Applications
1.3.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Comparison by Applications (2014-2025)
1.3.2 Liver Cancer
1.3.3 Respiratory Cancer
1.3.4 Brain Cancer
1.3.5 Others
1.4 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Overall Market
1.4.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (2014-2025)
1.4.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production (2014-2025)
1.4.3 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Status and Prospect (2014-2025)
1.4.4 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Status and Prospect (2014-2025)
1.4.5 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Status and Prospect (2014-2025)
1.4.6 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Status and Prospect (2014-2025)
1.4.7 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Status and Prospect (2014-2025)
1.4.8 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of B-Cell Maturation Antigen(BCMA) Targeted Therapies
2.3 Manufacturing Process Analysis of B-Cell Maturation Antigen(BCMA) Targeted Therapies
2.4 Industry Chain Structure of B-Cell Maturation Antigen(BCMA) Targeted Therapies

3 Development and Manufacturing Plants Analysis of B-Cell Maturation Antigen(BCMA) Targeted Therapies
3.1 Capacity and Commercial Production Date
3.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of B-Cell Maturation Antigen(BCMA) Targeted Therapies
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Production and Capacity Analysis
4.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Analysis
4.3 B-Cell Maturation Antigen(BCMA) Targeted Therapies Price Analysis
4.4 Market Concentration Degree

5 B-Cell Maturation Antigen(BCMA) Targeted Therapies Regional Market Analysis
5.1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Production by Regions
5.1.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production by Regions
5.1.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue by Regions
5.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption by Regions
5.3 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Analysis
5.3.1 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Production
5.3.2 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Import and Export
5.4 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Analysis
5.4.1 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Production
5.4.2 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Import and Export
5.5 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Analysis
5.5.1 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Production
5.5.2 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue
5.5.3 Key Manufacturers in China
5.5.4 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Import and Export
5.6 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Analysis
5.6.1 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Production
5.6.2 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Import and Export
5.7 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Analysis
5.7.1 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Production
5.7.2 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Import and Export
5.8 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Analysis
5.8.1 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Production
5.8.2 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue
5.8.3 Key Manufacturers in India
5.8.4 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Import and Export

6 B-Cell Maturation Antigen(BCMA) Targeted Therapies Segment Market Analysis (by Type)
6.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production by Type
6.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue by Type
6.3 B-Cell Maturation Antigen(BCMA) Targeted Therapies Price by Type

7 B-Cell Maturation Antigen(BCMA) Targeted Therapies Segment Market Analysis (by Application)
7.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption by Application
7.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Market Share by Application (2014-2019)

8 B-Cell Maturation Antigen(BCMA) Targeted Therapies Major Manufacturers Analysis
8.1 Transposagen Biopharmaceuticals
8.1.1 Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Sites and Area Served
8.1.2 Transposagen Biopharmaceuticals Product Introduction, Application and Specification
8.1.3 Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Sutro Biopharma
8.2.1 Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Sites and Area Served
8.2.2 Sutro Biopharma Product Introduction, Application and Specification
8.2.3 Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Malin Corporation
8.3.1 Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Sites and Area Served
8.3.2 Malin Corporation Product Introduction, Application and Specification
8.3.3 Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Eureka Therapeutics
8.4.1 Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Sites and Area Served
8.4.2 Eureka Therapeutics Product Introduction, Application and Specification
8.4.3 Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 firstVentury Equity
8.5.1 firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Sites and Area Served
8.5.2 firstVentury Equity Product Introduction, Application and Specification
8.5.3 firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Five Prime Therapeutics
8.6.1 Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Sites and Area Served
8.6.2 Five Prime Therapeutics Product Introduction, Application and Specification
8.6.3 Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Credit Suisse Securities
8.7.1 Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Sites and Area Served
8.7.2 Credit Suisse Securities Product Introduction, Application and Specification
8.7.3 Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Dana-Farber Cancer Institute
8.8.1 Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Sites and Area Served
8.8.2 Dana-Farber Cancer Institute Product Introduction, Application and Specification
8.8.3 Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Deerfield Partners
8.9.1 Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Sites and Area Served
8.9.2 Deerfield Partners Product Introduction, Application and Specification
8.9.3 Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Onyx Pharmaceuticals
8.10.1 Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Sites and Area Served
8.10.2 Onyx Pharmaceuticals Product Introduction, Application and Specification
8.10.3 Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Juno Therapeutics

9 Development Trend of Analysis of B-Cell Maturation Antigen(BCMA) Targeted Therapies Market
9.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Trend Analysis
9.1.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (Volume and Value) Forecast 2019-2025
9.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Regional Market Trend
9.2.1 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Forecast 2019-2025
9.2.2 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Forecast 2019-2025
9.2.3 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Forecast 2019-2025
9.2.4 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Forecast 2019-2025
9.2.5 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Forecast 2019-2025
9.2.6 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Forecast 2019-2025
9.3 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Trend (Product Type)
9.4 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 B-Cell Maturation Antigen(BCMA) Targeted Therapies Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of B-Cell Maturation Antigen(BCMA) Targeted Therapies
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Market Share by Types in 2018
Figure Bispecific Antibodies Product Picture
Figure Antibody Drug Conjugates Product Picture
Figure Chimeric Antigen Receptor T-Cells Product Picture
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Market Share by Applications in 2018
Figure Liver Cancer
Figure Respiratory Cancer
Figure Brain Cancer
Figure Others
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (Million USD) (2014-2025)
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production (K Units) (2014-2025)
Figure North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (Million USD) (2014-2025)
Figure Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (Million USD) (2014-2025)
Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (Million USD) (2014-2025)
Figure Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (Million USD) (2014-2025)
Figure Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (Million USD) (2014-2025)
Figure India B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (Million USD) (2014-2025)
Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of B-Cell Maturation Antigen(BCMA) Targeted Therapies in 2018
Figure Manufacturing Process Analysis of B-Cell Maturation Antigen(BCMA) Targeted Therapies
Figure Industry Chain Structure of B-Cell Maturation Antigen(BCMA) Targeted Therapies
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Manufacturing Plants Distribution
Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Capacity (K Units) of Major Manufacturers (2014-2019)
Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Production (K Units) of Major Manufacturers (2014-2019)
Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Market Share of Major Manufacturers (2014-2019)
Figure B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Share by Manufacturers in 2018
Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (Million US$) of Major Manufacturers (2014-2019)
Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share of Major Manufacturers (2014-2019)
Figure B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Share by Manufacturers in 2018
Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production by Regions 2014-2019 (K Units)
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Market Share by Regions 2014-2019
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Market Share by Regions in 2018
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue by Regions 2014-2019 (Million USD)
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share by Regions 2014-2019
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share by Regions in 2018
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption by Regions 2014-2019 (K Units)
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Market Share by Regions 2014-2019
Figure North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Growth Rate 2014-2019 (K Units)
Figure North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate 2014-2019 (Million USD)
Table North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Consumption Import and Export (K Units)
Figure Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Growth Rate 2014-2019 (K Units)
Figure Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate 2014-2019 (Million USD)
Table Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Consumption Import and Export (K Units)
Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Growth Rate 2014-2019 (K Units)
Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate 2014-2019 (Million USD)
Table China B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Consumption Import and Export (K Units)
Figure Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Growth Rate 2014-2019 (K Units)
Figure Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate 2014-2019 (Million USD)
Table Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Consumption Import and Export (K Units)
Figure Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Consumption Import and Export (K Units)
Figure India B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Growth Rate 2014-2019 (K Units)
Figure India B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate 2014-2019 (Million USD)
Table India B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Consumption Import and Export (K Units)
Figure Global Consumption B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Application (2014-2019)
Figure Global Value (Consumption) B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Application (2014-2019)
Table Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Sites and Area Served
Table Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Introduction, Application and Specification
Table Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Growth Rate (2014-2019)
Table Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Market Share (2014-2019)
Figure Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share (2014-2019)
Table Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Main Business and Markets Served
Table Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Sites and Area Served
Table Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Introduction, Application and Specification
Table Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Growth Rate (2014-2019)
Table Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Market Share (2014-2019)
Figure Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share (2014-2019)
Table Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Main Business and Markets Served
Table Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Sites and Area Served
Table Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Introduction, Application and Specification
Table Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Growth Rate (2014-2019)
Table Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Market Share (2014-2019)
Figure Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share (2014-2019)
Table Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Main Business and Markets Served
Table Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Sites and Area Served
Table Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Introduction, Application and Specification
Table Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Growth Rate (2014-2019)
Table Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Market Share (2014-2019)
Figure Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share (2014-2019)
Table Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Main Business and Markets Served
Table firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Sites and Area Served
Table firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Introduction, Application and Specification
Table firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Growth Rate (2014-2019)
Table firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Market Share (2014-2019)
Figure firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share (2014-2019)
Table firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Main Business and Markets Served
Table Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Sites and Area Served
Table Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Introduction, Application and Specification
Table Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Growth Rate (2014-2019)
Table Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Market Share (2014-2019)
Figure Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share (2014-2019)
Table Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Main Business and Markets Served
Table Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Sites and Area Served
Table Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Introduction, Application and Specification
Table Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Growth Rate (2014-2019)
Table Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Market Share (2014-2019)
Figure Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share (2014-2019)
Table Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Main Business and Markets Served
Table Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Sites and Area Served
Table Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Introduction, Application and Specification
Table Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Growth Rate (2014-2019)
Table Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Market Share (2014-2019)
Figure Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share (2014-2019)
Table Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Main Business and Markets Served
Table Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Sites and Area Served
Table Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Introduction, Application and Specification
Table Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Growth Rate (2014-2019)
Table Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Market Share (2014-2019)
Figure Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share (2014-2019)
Table Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Main Business and Markets Served
Table Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Sites and Area Served
Table Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Introduction, Application and Specification
Table Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Growth Rate (2014-2019)
Table Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Market Share (2014-2019)
Figure Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share (2014-2019)
Table Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Main Business and Markets Served
Table Juno Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Sites and Area Served
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production (K Units) Growth Rate Forecast 2019-2025
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Price (USD/Unit) Forecast 2019-2025
Figure North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Growth Rate Forecast 2019-2025 (K Units)
Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Growth Rate Forecast 2019-2025 (K Units)
Figure India B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of B-Cell Maturation Antigen(BCMA) Targeted Therapies by Type (2019-2025)
Table Global Consumption (K Units) of B-Cell Maturation Antigen(BCMA) Targeted Therapies by Application (2019-2025)
Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Distributors List
Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Transposagen Biopharmaceuticals、Sutro Biopharma、Malin Corporation、Eureka Therapeutics、firstVentury Equity、Five Prime Therapeutics、Credit Suisse Securities、Dana-Farber Cancer Institute、Deerfield Partners、Onyx Pharmaceuticals、Juno Therapeutics、

【免責事項】
https://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界のB細胞成熟抗原（BCMA）標的療法市場(Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Professional Survey Report 2019)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • HIV関連リポジストロフィー症候群治療の世界市場：規模・現状・予測
  • 世界のサバ産業：成長傾向・競合分析
  • 世界のリチウム金属二次電池産業：成長傾向・競合分析
  • 世界のオーディオビジュアルケーブル産業：成長傾向・競合分析
  • 世界のトラディショナル・バーチェア市場
  • 世界の信号トランス市場
  • 世界のポータブル加湿器市場
  • 世界のナノろ過膜市場
  • 世界のN,N-ジエチルエタノールアミン市場
  • 世界の等温核酸増幅技術（INAAT）市場
  • 世界のガラス瓶型市場
  • 世界のDPCセラミック基板市場
  • 世界の自動車用炭素繊維市場
  • 世界のアルミ鋳造製品市場
  • 世界のオールマウンテンスキー市場